SCHEMBL10488160

SCHEMBL10488160

O=C1CC[C@@H](O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2664314 1.00
SCHEMBL10481597 1.00
SCHEMBL22100982 0.83
SCHEMBL638389 0.83
SCHEMBL15564999 0.83 THRB (0.41)
SCHEMBL148906 0.81
SCHEMBL17867340 0.81 APEX1 (0.32)
SCHEMBL6312624 0.81
SCHEMBL6312937 0.79 TRIM24 (0.46)
SCHEMBL1891157 0.79 TRIM24 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111733195-B Method for preparing (1R, 3S) -3-aminocyclopentanol, integrase inhibitor and application 宁波酶赛生物工程有限公司 2023-06-30 CN claimed
CN-111733195-A Method for preparing (1R, 3S) -3-aminocyclopentanol, integrase inhibitor and application 宁波酶赛生物工程有限公司 2020-10-02 CN claimed
US-20260041860-A1 Breath-Enhanced Jet Nebulizer for HFNC Therapy UNIV NEW YORK STATE RES FOUND (US) 2026-02-12 US disclosed
EP-4615577-A1 METHODS OF TREATING EYE PAIN AND EYE DISORDERS Aisa Pharma, Inc. (US) 2025-09-17 EP disclosed
US-20250228842-A1 USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF CARCINOID SYNDROME Crinetics Pharmaceuticals, Inc. 2025-07-17 US disclosed
EP-4561655-A1 SYSTEM AND METHOD FOR ENHANCED AEROSOL DRUG DELIVERY DURING HIGH FLOW NASAL CANNULA THERAPY The Research Foundation for The State University of New York (US) 2025-06-04 EP disclosed
WO-2024102346-A9 METHODS OF TREATING EYE PAIN AND EYE DISORDERS AISA PHARMA, INC. (US) 2025-01-16 WO disclosed
EP-3991734-B1 AGENT FOR THE TREATMENT OF ALOPECIA AND PROMOTING HAIR GROWTH GURUS BIOPHARM INC (US) 2024-11-27 EP disclosed
EP-4463159-A1 USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF CARCINOID SYNDROME Crinetics Pharmaceuticals, Inc. (US) 2024-11-20 EP disclosed
CN-118510511-A Use of somatostatin modulators for the treatment of carcinoid syndrome 克林提克斯医药股份有限公司 2024-08-16 CN disclosed
WO-2024102346-A1 METHODS OF TREATING EYE PAIN AND EYE DISORDERS AISA PHARMA, INC. (US) 2024-05-16 WO disclosed
CN-115124493-A Compound with anti-inflammatory activity and preparation method and application thereof 江苏康缘药业股份有限公司 2022-09-30 CN disclosed
CN-115124546-A Tricyclic monoterpene compound and preparation method and application thereof 江苏康缘药业股份有限公司 2022-09-30 CN disclosed
US-20220249514-A1 REMEDY FOR HAIR GROWTH ENHANCING KOFF INVESTMENTS LLP (GB) 2022-08-11 US disclosed
EP-3991734-A1 AGENT FOR PROMOTING HAIR GROWTH Regeus Limited Liability Company (RU) 2022-05-04 EP disclosed
CN-112047826-B Guaiane type sesquiterpenoids and preparation method and application thereof 江苏康缘药业股份有限公司 2022-02-08 CN disclosed
CN-111733195-A Method for preparing (1R, 3S) -3-aminocyclopentanol, integrase inhibitor and application 宁波酶赛生物工程有限公司 2020-10-02 CN disclosed
CN-111733195-A Method for preparing (1R, 3S) -3-aminocyclopentanol, integrase inhibitor and application 宁波酶赛生物工程有限公司 2020-10-02 CN disclosed
US-7977465-B2 Peptidyl prodrugs and linkers and stabilizers useful therefor MEDAREX, INC. (US) 2011-07-12 US disclosed
US-4879421-A HYDROLYSIS OF DIESTER GENERAL ELECTRIC COMPANY (US) 1989-11-07 US disclosed